Aridis Pharmaceuticals Inc Asset Turnover Ratio (ARDS), as of third quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Aridis Pharmaceuticals Inc   (NASDAQ: ARDS)
 

Aridis Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Aridis Pharmaceuticals Inc asset turnover ratio, the ability of Aridis Pharmaceuticals Inc 's assets to generate revenue in the third quarter 2023, increased sequentially to 2.41 in the third quarter (Sep 30 2023), yet the ratio remained below the average, as ARDS's position remain challenging.

Within sector 21 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2023 compared to the preceding quarter from 3741 to 3840.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ARDS Asset Turnover Ratio (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Asset Change -46.09 % -61.15 % -60.39 % -45.1 % -53.54 %
Y / Y Revenue Change 4.51 % 6628.42 % -8.85 % 22.9 % -22.52 %
Asset Turnover Ratio (TTM) 2.41 2.09 0.23 0.18 0.14
ARDS's Total Ranking # 3840 # 3741 # 3275 # 3166 # 3067
Seq. Asset Change 0.8 % -31.29 % -35.8 % 21.25 % -27.36 %
Seq. Revenue Change -97.88 % 1715.8 % -10.8 % 204.01 % 36.64 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 22
Healthcare Sector # 41
Overall Market # 3840

Asset Turnover Ratio Statistics
High Average Low
47.33 15.67 3.46
(Jun 30 2023)   (Jun 30 2022)




ARDS Company Profile • Back to ARDS Efficiency Comparisons • Compare ARDS Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Assets at quarter ending Sep 30 2023
Longduoduo Co Ltd  4.96 $ 4.990  Millions$ 1.006  Millions
Gyre Therapeutics Inc   4.59 $ 79.758  Millions$ 17.388  Millions
Lifemd Inc   3.96 $ 134.262  Millions$ 33.918  Millions
Wearable Health Solutions, Inc.  3.91 $ 0.671  Millions$ 0.172  Millions
Lifevantage Corp  3.14 $ 212.421  Millions$ 67.629  Millions
Escalon Medical Corp   2.50 $ 12.520  Millions$ 5.000  Millions
Aridis Pharmaceuticals Inc   2.41 $ 22.359  Millions$ 9.286  Millions
Rosecliff Acquisition Corp I  2.28 $ 16.315  Millions$ 7.153  Millions
Healthcare Services Group Inc   2.27 $ 1,671.569  Millions$ 737.485  Millions
Patterson Companies Inc   2.26 $ 6,550.083  Millions$ 2,898.615  Millions
Interpace Biosciences Inc   2.16 $ 33.536  Millions$ 15.512  Millions
Hims and Hers Health Inc   2.05 $ 791.439  Millions$ 386.599  Millions
Agilon Health Inc   1.97 $ 4,190.633  Millions$ 2,124.683  Millions
Integrated Biopharma Inc  1.93 $ 50.567  Millions$ 26.251  Millions
Sunlink Health Systems Inc   1.92 $ 45.936  Millions$ 23.898  Millions
Nature s Sunshine Products inc   1.86 $ 437.245  Millions$ 235.107  Millions
Cano Health Inc   1.83 $ 3,101.906  Millions$ 1,698.139  Millions
Rockwell Medical inc   1.80 $ 80.147  Millions$ 44.438  Millions
Biofrontera Inc   1.79 $ 73.159  Millions$ 40.965  Millions
Privia Health Group Inc   1.76 $ 1,581.333  Millions$ 899.515  Millions
Kewaunee Scientific Corporation  1.75 $ 213.189  Millions$ 121.803  Millions
Mimedx Group Inc   1.75 $ 308.230  Millions$ 176.247  Millions
Encision Inc   1.66 $ 6.970  Millions$ 4.209  Millions
Progyny Inc   1.59 $ 1,031.980  Millions$ 650.190  Millions
Champions Oncology Inc   1.56 $ 49.978  Millions$ 31.972  Millions
Vycor Medical Inc   1.56 $ 1.424  Millions$ 0.914  Millions
International Stem Cell Corporation  1.52 $ 8.330  Millions$ 5.476  Millions
Neptune Wellness Solutions Inc   1.51 $ 43.724  Millions$ 28.863  Millions
Chemed Corporation  1.50 $ 2,225.159  Millions$ 1,485.114  Millions
Agile Therapeutics Inc  1.49 $ 19.189  Millions$ 12.850  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.